
|Articles|April 4, 2016
Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding
Author(s)DIA
Advertisement
Pharmaceutical compounding is an essential aspect of medicine in the US, although with inherent risks that must be understood and managed. In May 2016, the Special Section of
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
2
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
3
Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape
4
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
5




